These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23822892)

  • 1. Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis.
    Reade CJ; Riva JJ; Busse JW; Goldsmith CH; Elit L
    Gynecol Oncol; 2013 Sep; 130(3):674-81. PubMed ID: 23822892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Henderson JT; Webber EM; Sawaya GF
    JAMA; 2018 Feb; 319(6):595-606. PubMed ID: 29450530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
    Buys SS; Partridge E; Black A; Johnson CC; Lamerato L; Isaacs C; Reding DJ; Greenlee RT; Yokochi LA; Kessel B; Crawford ED; Church TR; Andriole GL; Weissfeld JL; Fouad MN; Chia D; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hartge P; Pinsky PF; Zhu CS; Izmirlian G; Kramer BS; Miller AB; Xu JL; Prorok PC; Gohagan JK; Berg CD;
    JAMA; 2011 Jun; 305(22):2295-303. PubMed ID: 21642681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening program in ovarian cancer: A logical step in clinical management? A meta-analysis.
    Marchetti C; De Felice F; Perniola G; Lecce F; Vertechy L; Monti M; Musio D; Muzii L; Tombolini V; Benedetti Panici P
    Curr Probl Cancer; 2018; 42(2):235-240. PubMed ID: 29433824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
    Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME
    J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening postmenopausal women for ovarian cancer: a systematic review.
    Fung MF; Bryson P; Johnston M; Chambers A;
    J Obstet Gynaecol Can; 2004 Aug; 26(8):717-28. PubMed ID: 15307976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of transvaginal ultrasound in screening for ovarian cancer.
    Campbell S; Gentry-Maharaj A
    Climacteric; 2018 Jun; 21(3):221-226. PubMed ID: 29490504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.
    van Nagell JR; Burgess BT; Miller RW; Baldwin L; DeSimone CP; Ueland FR; Huang B; Chen Q; Kryscio RJ; Pavlik EJ
    Obstet Gynecol; 2018 Nov; 132(5):1091-1100. PubMed ID: 30303916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Dec; 157(12):900-4. PubMed ID: 22964825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial.
    Partridge EE; Greenlee RT; Riley TL; Commins J; Ragard L; Xu JL; Buys SS; Prorok PC; Fouad MN
    Obstet Gynecol; 2013 Jan; 121(1):25-31. PubMed ID: 23262924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.
    Olivier RI; Lubsen-Brandsma MA; Verhoef S; van Beurden M
    Gynecol Oncol; 2006 Jan; 100(1):20-6. PubMed ID: 16188302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for ovarian cancer: a pilot randomised controlled trial.
    Jacobs IJ; Skates SJ; MacDonald N; Menon U; Rosenthal AN; Davies AP; Woolas R; Jeyarajah AR; Sibley K; Lowe DG; Oram DH
    Lancet; 1999 Apr; 353(9160):1207-10. PubMed ID: 10217079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging and Screening of Ovarian Cancer.
    Lowry KP; Lee SI
    Radiol Clin North Am; 2017 Nov; 55(6):1251-1259. PubMed ID: 28991564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
    Gilbert L; Basso O; Sampalis J; Karp I; Martins C; Feng J; Piedimonte S; Quintal L; Ramanakumar AV; Takefman J; Grigorie MS; Artho G; Krishnamurthy S;
    Lancet Oncol; 2012 Mar; 13(3):285-91. PubMed ID: 22257524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Barry MJ; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Krist AH; Kurth AE; Landefeld CS; Mangione CM; Phipps MG; Silverstein M; Simon MA; Tseng CW
    JAMA; 2018 Feb; 319(6):588-594. PubMed ID: 29450531
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.